Search results
Results from the WOW.Com Content Network
Pages in category "Companies that have filed for bankruptcy in Canada" The following 113 pages are in this category, out of 113 total. This list may not reflect recent changes .
Doxazosin, sold under the brand name Cardura among others, is a medication used to treat symptoms of benign prostatic hyperplasia (enlarged prostate), hypertension (high blood pressure), and post-traumatic stress disorder (PTSD). [1] [2] For high blood pressure, it is a less preferred option. [2] It is taken by mouth. [2]
Pages in category "Canadian subsidiaries of foreign companies" The following 135 pages are in this category, out of 135 total. This list may not reflect recent changes .
The pharmaceutical industry in Canada employs approximately 30,000 people. It supplies about one third of the domestic pharmaceutical consumer market of $27 billion annually. [1] This accounts for ~16% of yearly health expenditures. Canada had a pharmaceutical trade deficit of $8.5 billion in 2018 with exports of $11 billion and imports of $19. ...
Canada is the world's eighth-largest economy as of 2022, with a nominal GDP of approximately US$2.2 trillion. [1] It is a member of the Organisation for Economic Co-operation and Development (OECD) and the Group of Seven (G7), and is one of the world's top ten trading nations , with a highly globalized economy.
Two Indian chemical companies have been indicted for allegedly importing ingredients for the highly addictive opioid fentanyl into the United States and Mexico, the U.S. Department of Justice said ...
The S&P/TSX 60 Index is a stock market index of 60 large companies listed on the Toronto Stock Exchange.Launched on December 30, 1998 by the Canadian S&P Index Committee, [1] a unit of S&P Dow Jones Indices, the index has components across nine sectors of the Canadian economy.
Canada’s Health Research Foundation (HRF) is a non-profit organization that invests in health research in Canadian academic centres, and promotes the benefits and values of research-driven health innovation in Canada. Innovative Medicines Canada members pay an annual contribution of $1 million to the Foundation. [17]